• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痴呆症中的神经肽变化:发病机制意义及诊断价值

Neuropeptide changes in dementia: pathogenetic implications and diagnostic value.

作者信息

Valenti G

机构信息

University of Parma, Italy.

出版信息

Gerontology. 1996;42(5):241-56. doi: 10.1159/000213799.

DOI:10.1159/000213799
PMID:8940647
Abstract

The main object of this review is to describe the most significant alterations of neuropeptide patterns occurring in the brain and in the cerebral spinal fluid of demented patients and particularly of elderly patients with Alzheimer type dementia. The changes in concentration in the different brain areas are described along with their peripheral endocrine implications. Alterations in the synthesis and release of neuropeptides may play a significant role in the pathogenesis of dementia in elderly patients, in addition to the well known changes in classical neurotransmitter systems. Measurements of neuropeptide levels in cerebrospinal fluid or postmortem brain material as alleged biological markers for the diagnostic purpose, however, have produced controversial results. Neuropeptide changes in the demented brain show regional differences and are not specific and selective enough to differentiate between senile dementia, Alzheimer type dementia and other degenerative disorders.

摘要

本综述的主要目的是描述痴呆患者,尤其是患有阿尔茨海默型痴呆的老年患者大脑和脑脊液中神经肽模式的最显著变化。描述了不同脑区浓度的变化及其外周内分泌影响。除了经典神经递质系统中众所周知的变化外,神经肽合成和释放的改变可能在老年患者痴呆的发病机制中起重要作用。然而,将脑脊液或死后脑材料中的神经肽水平测量作为诊断目的的所谓生物标志物,其结果存在争议。痴呆大脑中的神经肽变化存在区域差异,且特异性和选择性不足以区分老年性痴呆、阿尔茨海默型痴呆和其他退行性疾病。

相似文献

1
Neuropeptide changes in dementia: pathogenetic implications and diagnostic value.痴呆症中的神经肽变化:发病机制意义及诊断价值
Gerontology. 1996;42(5):241-56. doi: 10.1159/000213799.
2
Neuropeptides and Alzheimer's disease.神经肽与阿尔茨海默病
Eur Neuropsychopharmacol. 1995 Dec;5(4):491-500. doi: 10.1016/0924-977x(95)00038-q.
3
Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.脑脊液生物标志物检测结果与神经病理痴呆诊断的关系。
Alzheimers Dement. 2010 Mar;6(2):104-9. doi: 10.1016/j.jalz.2009.12.005.
4
Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.脑脊液淀粉样蛋白-β亚型对早期及鉴别性痴呆诊断的诊断准确性
J Alzheimers Dis. 2015;45(3):813-22. doi: 10.3233/JAD-141986.
5
Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.阿尔茨海默病和额颞叶痴呆患者脑脊液中的神经肽
Dementia. 1993 May-Aug;4(3-4):167-71. doi: 10.1159/000107318.
6
Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.根据遗传和人口统计学特征进行分层可提高快速进展性痴呆患者脑脊液生物标志物的诊断准确性。
J Alzheimers Dis. 2016 Oct 18;54(4):1385-1393. doi: 10.3233/JAD-160267.
7
Altered CSF orexin and α-synuclein levels in dementia patients.痴呆症患者脑脊液中食欲素和α-突触核蛋白水平的改变。
J Alzheimers Dis. 2012;29(1):125-32. doi: 10.3233/JAD-2012-111655.
8
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.磷酸化tau表位测量在阿尔茨海默病鉴别诊断中的应用:一项脑脊液对比研究
Arch Gen Psychiatry. 2004 Jan;61(1):95-102. doi: 10.1001/archpsyc.61.1.95.
9
Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.脑脊液中β淀粉样肽在神经退行性痴呆诊断中的验证
Mol Psychiatry. 2007 Jul;12(7):671-80. doi: 10.1038/sj.mp.4001967. Epub 2007 Mar 6.
10
Neuropeptides and dementia.神经肽与痴呆症。
Prog Brain Res. 1986;66:143-59.

引用本文的文献

1
Clinical significance of neurobiochemical profiles in the lumbar cerebrospinal fluid of Alzheimer's disease patients.阿尔茨海默病患者腰椎脑脊液神经生化指标的临床意义
J Neural Transm (Vienna). 2001;108(2):231-46. doi: 10.1007/s007020170091.
2
Shunt related changes in somatostatin, neuropeptide Y, and corticotropin releasing factor concentrations in patients with normal pressure hydrocephalus.正常压力脑积水患者中与分流相关的生长抑素、神经肽Y和促肾上腺皮质激素释放因子浓度变化
J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):298-304. doi: 10.1136/jnnp.70.3.298.